{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-006839","form_type":"8-K","ticker":"TBRG","cik":"0001169445","company_name":"TruBridge, Inc.","filed_at":"2025-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.075440+00:00","generated_at":"2026-05-25T00:51:44.713404+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"TruBridge reports FY2024 revenue $339.2M, net loss $23.1M; issues FY2025 guidance","bullets":["Q4 2024 revenue $87.4M (up 1.7% YoY); adjusted EBITDA $17.2M vs $12.0M YoY.","Full-year 2024 adjusted EBITDA $53.1M (up 11.5% YoY); net loss $23.1M vs $33.2M loss in 2023.","Financial Health segment revenue $216.1M (up 11.5% YoY), 63.7% of total; recurring revenue 94.4%.","Debt repayment reduced leverage ratio from 4x to ~3x YoY; divested AHT business.","FY2025 revenue guidance $345-360M, adjusted EBITDA $59-66M; Q1 2025 rev $85-88M, adj. EBITDA $14-16M."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-006839","json":"https://secwatch.observer/filing/0001437749-25-006839.json","markdown":"https://secwatch.observer/filing/0001437749-25-006839.md","text":"https://secwatch.observer/filing/0001437749-25-006839.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1169445/000143774925006839/0001437749-25-006839-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1169445/000143774925006839/cpsi20250310_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T00:51:44.713404+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}